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A homologue of dystrophin is expressed at the ~~~~~rnu~cu~~~ j nctions 
of normal individuals and DMD patients, and of normai and nscJx mice 
~rn~u~~~~~i~~~ evidence 
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Palyelanal snd monsclonrl antibodies, which recognize different regions and epitopes of the dynrophin malccule. bind lo a protein of M, 400860 
which is present in extracts of n~r/.v mutile from regions which contain neuromuscular junctions (NMJ) nnd is absent from those which do not. 
This NMJ.aasaciatrd homologuc of dyrtrophin has at Icast 2 cpitops which are diflercnt to the usual Xp21 fcrrm of dyotrephin cxprssrcd along 
the snrculcmma of muscle fibrcs in narml nmxl~s. This protein is also cxprcsscd at the NMJ of N DMD patient who la&o the first 52 exons 
of the Xp2l dyrtraphin gcncund it must therefore be translated from a different gcnc transcript. 
Dystrophin: Ncuromusculnr junction (NW); Dystrophin related protein (DRP) 
1, INTRODUCTION 
Dystroghin is the protein product of a gene localized 
at the locus Xp21 [1,2] and expressed at the periphery 
of skeletal muscle fibers [3-71. This gene is affected in 
Duchenne muscular dystrophy (DMD) patients and 
rndjc mice through mutations which disrupt the reading 
frame of the transcript preventing dystrophin expres- 
sion in the corresponding skeletal muscles [g-14]. I-Iigh 
concentrations of dystrophin (or a dyscrophin-like pro- 
tein) have been observed at the neuromuscular junc- 
tions (NMJ) in normal rats, rabbits or mice as well as 
in the electric organ of Torpedo marmwata [15-181. 
Fardeau et al. [19] recently reported a positive im- 
munofluorescence r sponse at the NMJ of DMD pa- 
tients and rndx mice, using antibodies raised against he 
central and distal parts of chicken skeletal muscle 
dystrophin [20,21]. 
We now observe aprotein of Mr 400000 which is pre- 
sent in extracts of mdx muscle from regions which con- 
tain NMJs and is absent from those which do not. This 
NMJ-associated homologue of dystrophin has at least 
2 epitopes which are different to the usual Xp21 form 
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of dystrophin expressed along the sarcolcmma of mus- 
cle fibres in normal muscles. This protein is also ex- 
pressed at the NMJ of a DMD patient who lacks the 
first 52 exons of the Xp21 dystrophin gene. 
2. MATERIALS AND METI-IODS 
2.1. Biopsy tnarerials and diagnoses 
The patient was a g-year-old male who has followed a severe, 
Duchcnne course and is also mentally retarded. No hybridization 
signal was obtained with the DMD cDNA probes l-2a. 2b-3,4-Sa, 
Sb-7 and 8 (American Type Culture Collection, depositor L.M. 
Kunkcl) an Southern blotting. According to PCR, no signal was ob- 
tained for exons 3, 4, 6, 8, 12, 17, 19, 44, 45, 48, 50, 51, 52 (probes 
were gift of Drs J. Chamberlain [22] and A. Beggs). The first axon 
detected was exon 60. Consequently this DMD patient carries a dcle- 
tion spanning at least the first 52 exons of the 7S+ which form the 
Xp21 transcript [23]. The control muscle biopsy was from a patient 
with an ocular myopathy and no apparent dystrophin deficiency. 
2.2. Preparation of polyclonal and tnonoclonal antibodies 
Polyclonal antibodies were generated from rabbits immunized with 
3 recombinant fusion proteins constructed from different fragments 
of chicken skeletal muscle dystrophin cDNA [20] and spanning the 
amino-terminal domain (serum A: residues 43-760), part of the cen- 
tral rod domain (serum C: residues 1173-1728) and the entire 
carboxy-terminal domain (serum l-l: residues 3357-3660) of chicken 
dystrophin [20,2l] (N. Augier et a!., unpublished). MAb Dy4/6D3 
and MAb DyW6C5 were obtained by lymphocyte hybridation from 
mice immunized either by the 30 kDa fusion protein spanning a part 
of the central rod domain of mouse cardiac muscle dystrophin 
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Indirect lmmuno~uorcrtrnee ~8s performed on ICL cm thick dcc- 
rlano of mouse and hurwn murelas frozen in irclpenranc, 8s in [W). 
For Western blotting, 10 serial l0rm thick cryoa*I rrcrlono, adja= 
Ccnl 18 aec~lonr used for control immunafluorra~cnizs studier (noi 
shown), were homogonlwod In 40~1 of gal loadinp SDS-conrainin# 
bufler according to [he previously dereribcd Western blotting micro 
procadurs 1241. One ol1 cryorrrt 9zetions wfrc immcdlnrcly examin. 
ed for [heir possible NM1 cotrlcnl by determining aeerylcholine 
cstertlre activity [ZS!. Abrenec of dyatrophln a~ the periphery of muss 
sic fibres was vcrlficd in all nrrlx muscle.9 used for homoyennteo. IO rl 
sninpleti wcrc applied on 0.75 mm SDS-polyrrrylamidc gels, using a 
2% IO 7% gradient gel and non-stncking gel cantnining25% glycerol, 
The nmount al muaclc extracts applied were a posrcrlori controlled 
by mcnrurlng their C~omasslc detected myosin con~cnt, Trmrt”cr and 
immunosraining procedures were pcrlormcd as in 1241% Alknlinc 
phoaphatnsc labcllcd sntimrnbbit or anti-mouse antibodies (Miles) 
wcrc used ror Inbelling, 
fercnr polyclanal an&-a raised sgaixst rhc N-terminal 
end (anrirewm A), one. part of the ccnteat rod-like da- 
main (antiserum C) and the Gtcrminal end (antiserum 
El) of chicken skeletal muscle dystropkin (191, These 
regions show Xi%, 75% and 95% conscrvarion raspec~ 
rivcly, with the human skeletal muscle sequence [20], 
To determine the relarive molecular mass of rhc pro, 
rein(s) detected by indirect immunofluorescence with 
the 3 dystrophin antisera 1191, extracts prepared from 
innervated or non-innervared regions of diaphragm 
muscles from normal and nr(L~ mice were analyzed by 
Western blotting. A thin immunoreactivc band of ap- 
proximately M, 400000 was detected in extracts of in. 
nervated r&x mouse muscle by the polyclonal antisera 
raised against he central (Fig. 123, lane 1) and distal 
regions (not shown) of chicken skeletal muscle 
A. IL 
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Fig. 1. Comparative immunoanalyses of dystrophin expression at the NMJ in the diaphragm muscle of mdx and control mice. Total extracts from 
cryostat sections of innervated and non-innervated muscle regions of an adult mdx mouse (lanes 1, 2 respectively) and of an adult C57BL/lO 
control mouse (lanes 3, 4, respectively) were compared by western blotting analysis using either poiyclonai aniibodiCs iaisdd against 3 ciiffwmt 
regions of the chicken skeletal muscle dystrophin [20,21] or 3 MAbs which recognise different domains of human skeletal muscle dystrophin 
[11,12]. The same amount of extracts were applied in all panels. Panel A shows the Coomassie blue staining of the muscle ext,,acts; panel B shows 
the labelling observed with the polyclonal antiserum raised against the central part of the chicken dystrophin (serum C) [al]; and panel C shows 
the labelling observed with MAb DyWBCS raised against the last 17 C-terminal residues of human skeletal muscle dystrophin. 
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dyrtrophin. The 4BOK band was absent in ~tract~ made 
from nan=innervutcd re&ma of rnR& mouse muxte 
the atxistent‘c caF an NMJ ~~~lrrtsrf protein which her 
(Fig. 18, lane 21, A thick immunoreacrivt: band of &f, 
structural tramolalgy (t3 dyw~phln In 3 differenr 
demwinr. 
the central (Fig lB, lrinc 3, 4) and distal (not shown) 
regions of chicken skclctnl mwele dyaerophin. The rhin 
immunorenecive band detected in the extracts made 
antibodies (MAbs) eeaerinra with rhc conventional form 
af mrraelc dystraphin were applied on the same extracts 
made Pt-tlm innervated and nan.innervated rcgiona of 
from innervated regions of tn& mouse muscle 
migtated rouyhty to the same position as the major 
dystrophin band found along the rarcolcmma of nor. 
I&X and normal mou?Lc muscles. The UAbs were 
By4/6B3 [l l] which rccqniscs an epitope in the ten. 
rral rod domain (3OK fusion protein [2]) in E\ region 
ma1 skeletal muscle fibres. It therefore has a similar, if 
nor identical relative molecular mass. other bands with 
apru~ned by polyelonnl antixrum C; Dy8/6C5 which 
rwogniscs an cpitope within the last 17 carboxy- 
lower JM, were weakly stained in non-innervated or in” 
nervated muscle regions of normal and ttrc& muscle by 
the polyelonal antisera. These bands could be due to 
some dystrophin protcolysis or to some weak crossreac. 
tivities of the polyclonal antisera wick other muselc pro- 
reins [5,6,26,27] 1 Mcvcrthelcss, rho most intense 
terminal dystrophin residues in a reyion apannecl by an- 
tinerum M; and I&18, which recogniccs an epitope: in 
the last 303 residues (3357-3660) of the carbaxy de- 
main of chicken skeletal museie dystraphin, Unlike 
Dy8/6CS, Dyl8 does not react in ELISA experiments 
with a synthetic peptidc consisting of the! last 17 amino 
immune signal detected in the cxtcacts made from in- 
ncrvatcd regions of nt& mouse muscle was clearly 
found at the level of the 400K band. Considering the 
acids of the C-terminus of the skeleta1 muscle 
dystrophin. MAb By18 reacted with the thin NMJ- 
associated 400K band previously observed in n&e mus- 
current evidence From blots and the previous im- 
munofluorcScerree experiments [19], we suggest that the 
immunorcactivity detected by both methods indicates 
clc with the 3 polyclonal antisera (not shown, as in 
Fig. lB), In contrast,, neither of the 2 ocher MAbs 
reacted with the NMJ-associated 400K band in r71& 
Antiserum M BtX Dy8/6C% BPX Dyl8 lax 
Fig. 2. Comparative immunocytochcmical analysis of serial innervated muscle sections from a B-year-old DMD patient with a deletion spanning 
at least the 52 first exons of the Xp21 gene and from a non dystrophin-deficient adult control. The sections were incubated with the polyclonal 
antibodies raised against 3 different regions of the chicken skeletal muscle dystrophin [19-221 or with 3 MAbs which recognise different domains 
of Rttniita skeletal muscle dystrophin Ill, 121. Bach panel presents the NM3 loca!ization by rhodamine labelled a-bungarot’cxin (F&X) [19]. Panel 
A shows the labelling observed with the polyclonal serum raised against the C-terminal part of the chicken dystrophin (serum H) [19-211. Panel 
B shows the labelling observed with MAb DyW6CS raised against the last 17 C-terminal residues of human skeletal muscle dystrophin [12]. Panel 
C shows the Inbelling observed with MAb Dy18 raised against the C-terminal domain (residues 3357-3660) of chicken dystrophin [20]. Bars = 
muscle (Fig, ICI, lancw I and 21, All 3 MAbs reaetetl 
with the dyatrophin expressed innormal. mouse musclca 
(Fig. 113 and C, lanes 3 and 4). We conclude that the 
NM.!-associated homologue of dysttophin is im- 
munelegically (structurally) distifict from Xp21 cncad- 
ed dysrrophin in at leaat 2 epitopcs from different 
domains and is similar in at least one epitopc at the C- 
terminal end, 
The immunoanalyais was confirmed by eompnring 
the renetivity of the same set of 3 polycional antisera 
and 3 MAbs on cryostat sections of skeletal muscle 
from a non dystrophin-deficient control and from a 
DMD patient with a deletion spanning ztt least the first 
52 axons of the 75-t- which form the Xp21 transcript 
[23]. Positive immunoreactivity was observed at the: 
NMJ of the DMD patient and at the NMJ and sar- 
colemma of normal muscle using the polyclonal an- 
tisera (see Fig. 2R, the reaction with the antiserum 
against the C-terminal end) and MAb Dylg (Fig. 2C). 
In contrast, both MAb Dy4/6D3 and Dyg/6CS stained 
the periphery of normal muscle fibrcs but not NMJ of 
the DMD patient. Staining with both MAbs was 
detected at the NMJ of the normal human muscle, in- 
dicating that normal XpZl dystrophin is also exprcsscd 
at the NMJ (see Fig. 2B, the reaction with the MAb 
raised against the last 17 C-terminal dysrrophin 
residues). 
We have thus been able to demonstrate the existence 
of an MT 4oOooO NMJ-associated homologue of 
dystrophin which is expressed inmuscle from DMD pa- 
tients and mdx mice as well as from normal controls. 
The protein was detected by antisera which were 
generated by immunization with fusion proteins con- 
taining cDNA sequences from 3 distinct regions of 
chicken skeletal muscle dystrophin. The antisera may 
contain 2 populations of antibodies: those which 
demonstrate conventional iabelling of dystrophin at the 
sarcolemma, and those which show labelling which is 
restricted to neuromuscular junctions. It is well known 
that such recombinant fusion proteins may generate an- 
tibodies to dystrophin plus other structurally related 
proteins 126,271. 
The NMJ-associated protein we describe here could 
not be an isoform of Xp21 encoded dystrophin 
generated by alternative splicing because the NMJ pro- 
tein was detected in muscle from a DMD patient in 
whom the Xp21 locus was substantially deleted. Such a 
mechanism could have been hypothesised for the NMJ 
protein detected in mdx mouse muscle, since a simple 
point mutation has been identified as the gene defect in 
this strain I%]. 
A second possibility is that this NMJ protein is the 
chromosome 6eencoded homologue with a C-terminal 
sequence similar to that of Xp21 encoded dystrophin 
which has been identified in fetal muscle [293. Khurana 
et al. have recently isolated part of this chromosome 6
encoded cDNA by polymerase chain reaction cloning, 
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expressed tliilr as a recombinant b~~t~rjal prgtcln and 
raislrd polydonal ~ntib~d~~~ which reeagnisc a 
‘dyrtrophln r&t& protein” (DRP) [30), The ‘DRP’ is 
reported tu oxaerly co-migrate wlrh dystropkin as 8ur 
NM&associated homologw. We have recently dater* 
mined that MAb Dylg (bur neither of tha other MAbm) 
reacts with the recombinant bacterial protein issued 
from the chromosome 6encoded cDNA and with a pro= 
tein of M, similar to NMJ prorcin or DRP fn brain and 
liver in normal mice (data not shown). Therefore ths 
NMJ hornologue appears to share at least one commcm 
epiropc with the DRP and with the conventianal 
dystrophin. 
The third possibility is that the NMJ=aasoeiated pro= 
tcin we describe is a member of the family of 
dystrophin homologues which is encoded by a gene that 
has not yet been identified. It seems possible that the 
function of such an NMJ homologue might be related 
to the maintenance of membrane stability during ion 
exchange activities and dcnervation or cross- 
innervation experiments might be informative on this 
point. The generation of monoclonel antibodies which 
are specific for the chromosome 6protein or the NMJ- 
associated protein, and which react on both blots and 
tissue sections, will be essential for us to distinguish 
between these homoiogues and to investigate the poren- 
tial role of these proteins in normal and diseased 
tissues. 
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